JAC Advance Access originally published online on May 13, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Journal of Antimicrobial Chemotherapy (2003) 51, 1339-1350
© 2003 The British Society for Antimicrobial Chemotherapy
Review Article |
Antibiotics and hospital-acquired Clostridium difficile-associated diarrhoea: a systematic review
1 School of Biomedical and Chemical Sciences, The University of Western Australia, Queen Elizabeth II Medical Centre, Nedlands, Perth; 2 School of Population Health, The University of Western Australia, Clifton Street, Nedlands, Perth; 3 Division of Microbiology, The West Australian Centre for Pathology and Medical Research, Nedlands, Perth, Western Australia, 6009
A systematic review of studies that investigated the association of antibiotics with hospital-acquired Clostridium difficile-associated diarrhoea (CDAD) was undertaken to summarize the strength of the evidence for this relationship. The results from the studies identified were considered after critically reviewing the design and conduct of each study. Although the majority of studies found an association with various antibiotics, antibiotic classes or components of antibiotic administration, most were limited in their ability to establish a causal relationship by the use of incorrect control groups, the presence of bias, inadequate control of confounding and small sample sizes. The limitations identified in this review prevented the pooling of results in a meta-analysis. Two studies of reasonable quality suggested an association between clindamycin, cephalosporins, penicillins and CDAD. Well-designed studies grounded in epidemiological principles are needed to identify true risk factors for CDAD and to provide reliable estimates of the strength of association.
Keywords: Clostridium difficile, systematic review
* Correspondence address. School of Biomedical and Chemical Sciences, The University of Western Australia, Queen Elizabeth II Medical Centre, Nedlands, Perth, Western Australia, 6009. Tel: +618-9346-3440; Fax: +618-9382-8046; E-mail: c-thomas{at}cyllene.uwa.edu.au
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  U. A. Ochsner, S. J. Bell, A. L. O'Leary, T. Hoang, K. C. Stone, C. L. Young, I. A. Critchley, and N. Janjic Inhibitory effect of REP3123 on toxin and spore formation in Clostridium difficile, and in vivo efficacy in a hamster gastrointestinal infection model J. Antimicrob. Chemother., May 1, 2009; 63(5): 964 - 971. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Aldeyab, S. Harbarth, N. Vernaz, M. P. Kearney, M. G. Scott, C. Funston, K. Savage, D. Kelly, M. A. Aldiab, and J. C. McElnay Quasiexperimental Study of the Effects of Antibiotic Use, Gastric Acid-Suppressive Agents, and Infection Control Practices on the Incidence of Clostridium difficile-Associated Diarrhea in Hospitalized Patients Antimicrob. Agents Chemother., May 1, 2009; 53(5): 2082 - 2088. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Blondeau What have we learned about antimicrobial use and the risks for Clostridium difficile-associated diarrhoea? J. Antimicrob. Chemother., February 1, 2009; 63(2): 238 - 242. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. A. Wargo, B. M. Wright, and R. Gupta The Utility of Fluoroquinolones in the Critically Ill Journal of Pharmacy Practice, October 1, 2008; 21(5): 346 - 355. [Abstract] [PDF]
|
|
|
|
|
|
N. Vernaz, H. Sax, D. Pittet, P. Bonnabry, J. Schrenzel, and S. Harbarth Temporal effects of antibiotic use and hand rub consumption on the incidence of MRSA and Clostridium difficile J. Antimicrob. Chemother., September 1, 2008; 62(3): 601 - 607. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M.N. Choudhry, H. Soran, and H.M. Ziglam Overuse and inappropriate prescribing of proton pump inhibitors in patients with Clostridium difficile-associated disease QJM, June 1, 2008; 101(6): 445 - 448. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. M. Davies, J. Grinyo, R. Heading, B. Maes, H.-U. Meier-Kriesche, and M. Oellerich Gastrointestinal side effects of mycophenolic acid in renal transplant patients: a reappraisal Nephrol. Dial. Transplant., September 1, 2007; 22(9): 2440 - 2448. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Collini, M. Beadsworth, J. Anson, T. Neal, P. Burnham, P. Deegan, N. Beeching, and A. Miller Community-acquired pneumonia: doctors do not follow national guidelines Postgrad. Med. J., August 1, 2007; 83(982): 552 - 555. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. J. Asha, D. Tompkins, and M. H. Wilcox Comparative Analysis of Prevalence, Risk Factors, and Molecular Epidemiology of Antibiotic-Associated Diarrhea Due to Clostridium difficile, Clostridium perfringens, and Staphylococcus aureus. J. Clin. Microbiol., August 1, 2006; 44(8): 2785 - 2791. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. K. Keel and J. G. Songer The Comparative Pathology of Clostridium difficile-associated Disease Vet. Pathol., May 1, 2006; 43(3): 225 - 240. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. M. Musher, N. Logan, V. Mehendiratta, R. E. Polk, M. Oinonen, A. Pakyz, M. H. Wilcox, J. Freeman, K. Iwata, A. Doi, et al. Epidemic Clostridium difficile. N. Engl. J. Med., March 16, 2006; 354(11): 1199 - 1203. [Full Text] [PDF]
|
|
|
|
 |
|
 J. Starr Clostridium difficile associated diarrhoea: diagnosis and treatment BMJ, September 3, 2005; 331(7515): 498 - 501. [Full Text] [PDF]
|
|
|
|
 |
|
 D. E. Voth and J. D. Ballard Clostridium difficile Toxins: Mechanism of Action and Role in Disease Clin. Microbiol. Rev., April 1, 2005; 18(2): 247 - 263. [Abstract] [Full Text] [PDF]
|
|